Question 1

What is the share price of Aurobindo Pharma Limited today?

Accepted Answer

Aurobindo Pharma Limited (AUROPHARMA) is trading at ₹1,694.5. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is AUROPHARMA’s P/E ratio versus the sector?

Accepted Answer

AUROPHARMA trades at a P/E of 37.4. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is AUROPHARMA’s dividend yield?

Accepted Answer

AUROPHARMA has a dividend yield of 0.24%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is AUROPHARMA’s 52-week high and low?

Accepted Answer

AUROPHARMA has traded between ₹1,106 and ₹1,740 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Aurobindo Pharma Limited?

Accepted Answer

Aurobindo Pharma Limited has a market capitalisation of ₹97,411 crore.

Question 6

What is AUROPHARMA’s return on equity?

Accepted Answer

AUROPHARMA reports a return on equity of 11.2%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - Specialty & Generic.

Question 7

Who are AUROPHARMA’s competitors?

Accepted Answer

The Peers block on this page lists other Drug Manufacturers - Specialty & Generic companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is AUROPHARMA’s promoter holding?

Accepted Answer

Promoters hold 51.88% of AUROPHARMA. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include AUROPHARMA?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight AUROPHARMA carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Aurobindo Pharma Limited a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from AUROPHARMA’s own numbers. The judgement is yours.

Revenue	₹11,172 crore
Net profit	₹2,415 crore
Operating margin	28%
EPS	₹41.58

AUROPHARMA

AUROPHARMA

Fundamental Strength Index

Profitability

Growth

Segment Results

Working Capital & Efficiency

AUROPHARMA financial summary